title: Suitability of Trinidad/Tobago as a potential site for phase III efficacy studies of HIV-1 vaccines.
authors.affiliation: Ministry of Health, Roundabout Plaza, Barataria, Trinidad.
authors.forename: R
authors.initials: R
authors.lastname: Paul
authors.forename: F
authors.initials: F
authors.lastname: Cleghorn
authors.forename: N
authors.initials: N
authors.lastname: Jack
authors.forename: J
authors.initials: J
authors.lastname: Edwards
authors.forename: B
authors.initials: B
authors.lastname: Mahabir
authors.forename: J
authors.initials: J
authors.lastname: Murphy
authors.forename: W
authors.initials: W
authors.lastname: Blattner
authors.forename: C
authors.initials: C
authors.lastname: Bartholomew
mesh_terms: D016915:AIDS Vaccines / Q000494:pharmacology*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D008297:Male; D014300:Trinidad and Tobago / Q000453:epidemiology
chemical_list: D016915:AIDS Vaccines